Skip to Content

How does Besponsa work to treat acute lymphoblastic leukemia (ALL)?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017
Besponsa (inotuzumab ozogamicin), from Pfizer, is a CD22 monoclonal antibody and calicheamicin cytotoxic agent conjugate for relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) in adults. Besponsa works by binding to B-cell ALL cancer cells that express the CD22 antigen and blocks the growth of cancerous cells.
Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What is the difference between Biktarvy and Descovy?

Posted 7 Mar 2018 1 answerFAQ by Drugs.com

What is the difference between Symdeko and Orkambi?

Posted 7 Mar 2018 1 answerFAQ by Drugs.com

Is “Ambien-Tweeting” a Thing?

Posted 18 days ago 1 answerFAQ by Drugs.com